Ischemic Stroke: Clinical Trials

29 trials for Ischemic Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 terminated. 29 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 329Terminated 29
Phase 26Terminated 6

Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maimonides Minocycline in Stroke Study
Minocycline - Stroke, Acute, Ischemic Stroke
Phase 2 / Phase 3TerminatedMaimonides Medical Center22023-11-012025-12-17
Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT)
Tenecteplase - Stroke, Ischemic
Phase 3TerminatedGeneral Hospital of Shenyang Military Region1452023-03-212025-07-02
Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)
carbogen, phenylephrine - Acute Ischemic Stroke
Phase 3TerminatedYonsei University32021-04-052025-01-14
Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion
Tenecteplase, Standard Care (which may include intravenous Alteplase) - Ischemic Stroke
Phase 3TerminatedUniversity of Melbourne2422020-08-012025-01-15
The Norwegian Tenecteplase Stroke Trial 2
Tenecteplase, Alteplase - Stroke, Acute, Cerebrovascular Disorders
Phase 3TerminatedHaukeland University Hospital2012019-10-282025-03-03
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
MultiStem, Placebo - Ischemic Stroke
Phase 3TerminatedHealios K.K.2062018-07-282026-08-11
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Apixaban, Aspirin - Stroke
Phase 3TerminatedColumbia University10152018-01-192025-04-09
Tirofiban for Patients Treated With Alteplase
Tirofiban, Alteplase - Ischemic Stroke
Phase 2 / Phase 3TerminatedCapital Medical University302017-12-162020-09-09
Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)
SonoVue, Sodium chloride, Transcranial Ultrasound - Ischemic Stroke
Phase 3TerminatedUmeå University12017-11-282018-05-11
Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo - Stroke
Phase 3TerminatedBayer72132014-12-232019-01-09
DLBS1033 for Acute Ischemic Stroke Patients
DLBS1033, Placebo - Acute Ischemic Stroke, Partial Anterior Circulation Infarct
Phase 2 / Phase 3TerminatedDexa Medica Group802014-11-112023-12-12
DLBS1033 for the Treatment of Acute Ischemic Stroke
Placebo, DLBS1033 - Acute Ischemic Stroke
Phase 3TerminatedDexa Medica Group92014-10-012017-05-04
Cooling Plus Best Medical Treatment Versus Best Medical Treatment Alone for Acute Ischaemic Stroke
Hypothermia, Buspirone, Pethidine - Acute Ischemic Stroke
Phase 3TerminatedUniversity of Erlangen-Nürnberg Medical School982013-07-012019-10-02
IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset
The Ischemic Stroke System, Sham control - Ischemic Stroke
Phase 3TerminatedBrainsGate272013-05-012018-06-26
Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Transcranial ultrasound as an adjunctive therapy to tPA, Standard of care tPA therapy for acute ischemic stroke - Acute Ischemic Stroke
Phase 3TerminatedCerevast Therapeutics, Inc.6752013-05-012015-04-07
Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)
0.9% NaCl solution - Ischemic Stroke
Phase 3TerminatedChulalongkorn University1202013-05-012015-08-04
Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization
IV t-PA and normothermia, IV-tPA and hypothermia - Acute Ischemic Stroke
Phase 2 / Phase 3TerminatedUniversity of California, Los Angeles62013-02-012017-04-13
Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke
Endovascular thrombectomy/thrombolysis - Ischemic Stroke
Phase 3TerminatedUniversity of Calgary3162013-01-012015-03-23
Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours
Solitaire FR device, Medical treatment - Acute Stroke
Phase 3TerminatedFundacio Ictus Malaltia Vascular2062012-11-012016-02-03
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
DP-b99, Placebo - Acute Ischemic Stroke
Phase 3TerminatedD-Pharm Ltd.4462009-12-012012-10-24

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Stroke (14)  ·  Cerebrovascular Disorders (2)  ·  Hypothermia (2)  ·  Ischemic Attack, Transient (2)  ·  Acute Disease (1)  ·  Brain Ischemia (1)  ·  Carotid Stenosis (1)  ·  Cerebral Infarction (1)  ·  Constriction, Pathologic (1)  ·  Hemorrhagic Stroke (1)  ·  Intracranial Hemorrhages (1)  ·  Stroke, Lacunar (1)  ·  Thromboembolism (1)  ·  Thrombosis (1)

Broader conditions

Brain Diseases (29)  ·  Cardiovascular Diseases (29)  ·  Central Nervous System Diseases (29)  ·  Nervous System Diseases (29)  ·  Vascular Diseases (29)  ·  Cerebrovascular Disorders (27)  ·  Stroke (15)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Brain Ischemia (3)  ·  Pathologic Processes (3)  ·  Body Temperature Changes (2)  ·  Brain Infarction (2)  ·  Embolism and Thrombosis (2)  ·  Infarction (2)  ·  Ischemia (2)

Interventions

Abciximab (3)  ·  Aspirin (3)  ·  Tenecteplase (3)  ·  Tissue Plasminogen Activator (3)  ·  DLBS 1033 (2)  ·  Sodium Chloride (2)  ·  Standard of Care (2)  ·  Albumins (1)  ·  Buspirone (1)  ·  Clopidogrel (1)  ·  Cytidine Diphosphate Choline (1)  ·  DP-b99 (1)  ·  Fibrinolytic Agents (1)  ·  Meperidine (1)  ·  Minocycline (1)

Sponsors

Dexa Medica Group (2)  ·  University of Zurich (2)  ·  Bayer (1)  ·  BrainsGate (1)  ·  Capital Medical University (1)  ·  Centocor, Inc. (1)  ·  Cerevast Therapeutics, Inc. (1)  ·  Chulalongkorn University (1)  ·  Codman & Shurtleff (1)  ·  Columbia University (1)  ·  D-Pharm Ltd. (1)  ·  Ferrer Internacional S.A. (1)  ·  Fundacio Ictus Malaltia Vascular (1)  ·  General Hospital of Shenyang Military Region (1)  ·  H. Lundbeck A/S (1)

Countries

United States (11)  ·  Canada (8)  ·  Germany (6)  ·  Spain (6)  ·  Switzerland (5)  ·  Australia (3)  ·  Brazil (3)  ·  China (3)  ·  Finland (3)  ·  France (3)  ·  Israel (3)  ·  Italy (3)  ·  Portugal (3)  ·  South Africa (3)  ·  South Korea (3)

Top investigators

Ralf W. Baumgartner, MD (2)  ·  Alex Rovira, MD (1)  ·  Andrew M Demchuk, MD FRCPC (1)  ·  Angel Chamorro, MD (1)  ·  Ashfaq Shuaib, MD (1)  ·  Bryan Due, Ph.D. (1)  ·  Carlos Molina, MD (1)  ·  David S Liebeskind, MD (1)  ·  Diah H Soeryaningtias, Sp.S, MD (1)  ·  Dian Cahyani, Sp.S, MD (1)  ·  Dodik Tugasworo, Sp.S(K), MD (1)

Results publications

PMID 30045949, PMID 18032739, PMID 21546491, PMID 22691567, PMID 23390923, PMID 24076337, PMID 24335227, PMID 24473178, PMID 24699059, PMID 24815501, PMID 24828363, PMID 24876261, PMID 25342652, PMID 25428822, PMID 25671798, PMID 25791716, PMID 25803346, PMID 25858239, PMID 25882510, PMID 25953374, PMID 25984876, PMID 26120902, PMID 26138125, PMID 26325387, PMID 26486865, PMID 26508752, PMID 26542697, PMID 26892284, PMID 26956258, PMID 27076599, PMID 27462118, PMID 27803391, PMID 27834743, PMID 27924049, PMID 27940648, PMID 28292867, PMID 28318984, PMID 28336740, PMID 28468840, PMID 28483774, PMID 29021311, PMID 29096678, PMID 29170266, PMID 29187242, PMID 29191873, PMID 29203689, PMID 29525076, PMID 29766772, PMID 30878103, PMID 31008276

NIH funding

U01NS054630 (2), 2008 (1), 2018 (1), R01NS077706 (1), U01NS052220 (1), U01NS095869 (1)